Results 201 to 210 of about 1,303,402 (309)

Construction of UE4 model and virtual experience technology for Qiang ethnic architectural environment based on improved A* algorithm. [PDF]

Sci Rep
Lu Y.
europepmc   +1 more source

DANCER: Dance ANimation via Condition Enhancement and Rendering with diffusion model [PDF]

Y. M. Xing, J. H. Yin, Xiaodong Liu
openalex   +1 more source

Exploiting metabolic adaptations to overcome dabrafenib treatment resistance in melanoma cells

Molecular Oncology, EarlyView.
We show that dabrafenib‐resistant melanoma cells undergo mitochondrial remodeling, leading to elevated respiration and ROS production balanced by stronger antioxidant defenses. This altered redox state promotes survival despite mitochondrial damage but renders resistant cells highly vulnerable to ROS‐inducing compounds such as PEITC, highlighting redox
Silvia Eller, Susanne Ebner, Carmen Haselrieder, Julia K. Günther, Astrid Drasche, Sophie Strich, Chiara Volani, Andrea Medici, Aleksandar Nikolajevic, Alex Deltedesco, Johannes E. Sigmund, Michael J. Blumer, Martin Hermann, Johanna Vanacker, Gerald Brandacher, Eduard Stefan, Omar Torres‐Quesada, Jakob Troppmair   +17 more
wiley   +1 more source

Human reconstruction using 3D Gaussian Splatting: a brief survey. [PDF]

Front Artif Intell
Chen DL, Rahim MSM, Sim HM, Wang B, Chen S, Li MS.   +5 more
europepmc   +1 more source

GPU-friendly high-quality terrain rendering

, 2006
Jens Schneider, Rüdiger Westermann
openalex   +1 more source

ATF4‐mediated stress response as a therapeutic vulnerability in chordoma

Molecular Oncology, EarlyView.
We screened 5 chordoma cell lines against 100+ inhibitors of epigenetic and metabolic pathways and kinases and identified halofuginone, a tRNA synthetase inhibitor. Mechanistically halofuginone induces an integrated stress response, with eIF2alpha phosphorylation, activation of ATF4 and its target genes CHOP, ASNS, INHBE leading to cell death ...
Lucia Cottone, James Dunford, Eleanor Calcutt, Vicki Gamble, Filiz Senbabaoglu Aksu, Lorena Ligammari, Georgina Wherry, Giorgia Gaeta, John C. Christianson, Adrienne M. Flanagan, Udo Oppermann, Adam P. Cribbs   +11 more
wiley   +1 more source

Morphological Characteristics of Lateral Ankle Ligament Injuries Associated With Recurrent Instability After Arthroscopic Repair for Chronic Ankle Instability: 3D Volume Rendering MRI Model Analysis. [PDF]

Orthop J Sports Med
Sakurai S, Nakasa T, Ikuta Y, Kawabata S, Moriwaki D, Ishibashi S, Brilianto BI, Adachi N.   +7 more
europepmc   +1 more source

WildCap: Facial Appearance Capture in the Wild via Hybrid Inverse Rendering

Han, Yuxuan, Ming, Xin, Li, Tianxiao, Shen, Zhuofan, Zhang, Qixuan, Xu, Lan, Xu, Feng   +6 more
openalex   +1 more source

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

Molecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg, Joachim von Braun, Julio Celis, Anton Berns, Michael Baumann, Tit Albreht, Nancy Abou‐Zeid, Vanderlei Bagnato, Christian Brandts, Chien‐Jen Chen, Massimiliano di Pietro, Manjit Dosanjh, Thomas Dubois, Alexander Eggermont, Angelika Eggert, Ingemar Ernberg, Sara Faithfull, Johannes Förner, Stefan Fröhling, Manuel Heitor, Leroy Hood, Wei Jiang, Bengt Jönsson, Ravi Kannan, Maria Leptin, Su Li, Peter Lindgren, Douglas Lowy, Jun Ma, Alex Markham, Péter Nagy, Simon Oberst, M. Iqbal Parker, Danielle Rodin, Kevin Ryan, Joachim Schüz, Richard Sullivan, Josep Tabernero, Peter Turkson, Oliver Várhelyi, Harold Varmus, Chijie Wang, Elisabete Weiderpass, Nils Wilking   +43 more
wiley   +1 more source

Denoise-GS: Self-Supervised Denoising for Sparse-View 3D Gaussian Splatting. [PDF]

Sensors (Basel)
Xu Y, Ding J, Zhang J, Tan P, Li M.
europepmc   +1 more source